Core Viewpoint - The report from Tianfeng Securities indicates that the company Xinju Feng's net profit attributable to shareholders for H1 2025 is 60 million, a decrease of 31% year-on-year, while Q2 net profit is 46 million, an increase of 37% [1] Group 1: Financial Performance - In H1 2025, the company actively advances the "5 billion sterile packaging materials production project," focusing on high-end products and filling equipment market technology and experience accumulation [1] - The company's overseas wholly-owned subsidiary, Jingfeng Holdings, has completed a voluntary comprehensive offer to further acquire shares of Fenmei Packaging, excluding shares held by the offeror and its concerted parties [1] - As of the end of H1 2025, the transaction has been completed, and during the integration phase, the company will analyze the differences between both parties to enhance business synergy and promote deep integration and complementarity of advantages [1] Group 2: Profit Forecast and Valuation - Considering the company's H1 2025 performance, the synergistic effects from the acquisition of Fenmei, and the current market and consumer environment, the profit forecast has been adjusted [1] - The expected net profits attributable to shareholders for 2025-2027 are projected to be 170 million, 210 million, and 260 million respectively, compared to previous estimates of 220 million and 250 million for 2025-2026 [1] - The corresponding price-to-earnings ratios are expected to be 25x, 20x, and 16x for the years 2025, 2026, and 2027 respectively [1]

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [4]. Core Views - The company reported a revenue of 900 million in Q2 2025, representing a year-on-year increase of 132%, while the net profit attributable to the parent company was 46 million, up 37% [1]. - For the first half of 2025, the company achieved a revenue of 1.3 billion, a 52% increase year-on-year, but the net profit attributable to the parent company decreased by 31% to 60 million [1]. - The company is actively advancing the construction of a 5 billion sterile packaging material production project, focusing on high-quality and stable products [1]. - The company has completed the acquisition of a controlling stake in Fenmei Packaging, enhancing its control and integration capabilities [1][2]. Financial Performance - The adjusted profit forecast for the company estimates net profits attributable to the parent company for 2025, 2026, and 2027 to be 166.96 million, 208.22 million, and 256.37 million respectively, with corresponding P/E ratios of 24.88, 19.95, and 16.20 [3][8]. - The revenue projections for 2025, 2026, and 2027 are 2.56 billion, 2.94 billion, and 3.40 billion respectively, with growth rates of 49.79%, 14.87%, and 15.90% [3][8]. - The company’s total assets are projected to reach 3.87 billion in 2025, with a debt-to-asset ratio of 29.73% [9]. Business Integration - The company aims to strengthen business integration with Fenmei Packaging through management, team, and technology collaboration, enhancing operational efficiency and market competitiveness [2]. - The management integration includes maintaining Fenmei Packaging's Hong Kong listing status to enhance its international image and attract business opportunities [2]. - The technology integration focuses on collaborative research and development in filling machine technology and after-sales service, aiming to improve product competitiveness in the domestic market [2].

格隆汇7月31日丨新巨丰(301296.SZ)于投资者互动平台表示，公司无菌包装产品主要应用在液态奶和非 碳酸软饮料中，与胖东来暂无业务往来。公司将不断加强客户拓展，逐步提升市场份额。 ...

格隆汇7月31日丨新巨丰(301296.SZ)在互动平台表示，公司无菌包装产品主要应用在液态奶和非碳酸软 饮料中，与胖东来暂无业务往来。公司将不断加强客户拓展，逐步提升市场份额。 ...